As of Oct 21
| -0.0545 / -3.53%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 7.60, with a high estimate of 7.60 and a low estimate of 7.60. The median estimate represents a +410.23% increase from the last price of 1.49.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.